Literature DB >> 8389627

The acidic activation domain of the Epstein-Barr virus transcription factor R interacts in vitro with both TBP and TFIIB and is cell-specifically potentiated by a proline-rich region.

E Manet1, C Allera, H Gruffat, I Mikaelian, A Rigolet, A Sergeant.   

Abstract

In cells latently infected with Epstein-Barr virus (EBV), the expression of two viral transactivators, EB1 and R, is responsible for the switch from latency to a productive cycle. R contains a DNA-binding/dimerization domain localized at the N-terminus. The domain required for transcriptional activation is localized at the C-terminus and contains two regions of very different amino acid composition. The first is very rich in prolines, whereas the second is rich in acidic residues and contains two potential alpha-helices. We investigated the activation potential of these subregions when linked to the heterologous Gal4 DNA-binding domain. We found that the acidic region--more precisely, the second putative alpha-helix--is an activating domain. In contrast, the proline-rich region is insufficient by itself for activation but collaborates with the acidic region in a cell-specific manner to make transactivation more efficient. We demonstrated that R interacts in vitro with the basal transcription factors TBP and TFIIB, and that the acidic domain of R mediates these interactions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389627      PMCID: PMC6081622     

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  50 in total

1.  Reduced binding of TFIID to transcriptionally compromised mutants of VP16.

Authors:  C J Ingles; M Shales; W D Cress; S J Triezenberg; J Greenblatt
Journal:  Nature       Date:  1991-06-13       Impact factor: 49.962

2.  Binding of general transcription factor TFIIB to an acidic activating region.

Authors:  Y S Lin; I Ha; E Maldonado; D Reinberg; M R Green
Journal:  Nature       Date:  1991-10-10       Impact factor: 49.962

3.  Critical structural elements of the VP16 transcriptional activation domain.

Authors:  W D Cress; S J Triezenberg
Journal:  Science       Date:  1991-01-04       Impact factor: 47.728

4.  GAL4-VP16 is an unusually potent transcriptional activator.

Authors:  I Sadowski; J Ma; S Triezenberg; M Ptashne
Journal:  Nature       Date:  1988-10-06       Impact factor: 49.962

5.  Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA.

Authors:  J Countryman; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Epstein-Barr virus with heterogeneous DNA disrupts latency.

Authors:  G Miller; M Rabson; L Heston
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

7.  An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators.

Authors:  M A Cox; J Leahy; J M Hardwick
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

8.  Promoter specificity of basal transcription factors.

Authors:  J D Parvin; H T Timmers; P A Sharp
Journal:  Cell       Date:  1992-03-20       Impact factor: 41.582

9.  Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex.

Authors:  N Tanese; B F Pugh; R Tjian
Journal:  Genes Dev       Date:  1991-12       Impact factor: 11.361

10.  The transcriptional activation function located in the hormone-binding domain of the human oestrogen receptor is not encoded in a single exon.

Authors:  N J Webster; S Green; D Tasset; M Ponglikitmongkol; P Chambon
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

View more
  26 in total

1.  Mapping the sequences that mediate interaction of the equine herpesvirus 1 immediate-early protein and human TFIIB.

Authors:  H K Jang; R A Albrecht; K A Buczynski; S K Kim; W A Derbigny; D J O'Callaghan
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  The activation domain of herpesvirus saimiri R protein interacts with the TATA-binding protein.

Authors:  K T Hall; A J Stevenson; D J Goodwin; P C Gibson; A F Markham; A Whitehouse
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

3.  Marked variation in response of consensus binding elements for the Rta protein of Epstein-Barr virus.

Authors:  Lee-Wen Chen; Pey-Jium Chang; Henri-Jacques Delecluse; George Miller
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  Conserved interaction of the papillomavirus E2 transcriptional activator proteins with human and yeast TFIIB proteins.

Authors:  J D Benson; R Lawande; P M Howley
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  A novel transcriptional initiator activity of the GABP factor binding ets sequence repeat from the murine cytochrome c oxidase Vb gene.

Authors:  C Sucharov; A Basu; R S Carter; N G Avadhani
Journal:  Gene Expr       Date:  1995

6.  Functional interaction of the bovine papillomavirus E2 transactivation domain with TFIIB.

Authors:  J M Yao; D E Breiding; E J Androphy
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Characterization of the interaction between the acidic activation domain of VP16 and the RNA polymerase II initiation factor TFIIB.

Authors:  R Gupta; A Emili; G Pan; H Xiao; M Shales; J Greenblatt; C J Ingles
Journal:  Nucleic Acids Res       Date:  1996-06-15       Impact factor: 16.971

8.  A replication function associated with the activation domain of the Epstein-Barr virus Zta transactivator.

Authors:  R T Sarisky; Z Gao; P M Lieberman; E D Fixman; G S Hayward; S D Hayward
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

9.  Functional role of phosphatidylinositol 3-kinase/Akt pathway on cell growth and lytic cycle of Epstein-Barr virus in the Burkitt's lymphoma cell line, P3HR-1.

Authors:  Takako Mori; Takeshi Sairenji
Journal:  Virus Genes       Date:  2006-06       Impact factor: 2.332

10.  Two phenylalanines in the C-terminus of Epstein-Barr virus Rta protein reciprocally modulate its DNA binding and transactivation function.

Authors:  Lee-Wen Chen; Vineetha Raghavan; Pey-Jium Chang; Duane Shedd; Lee Heston; Henri-Jacques Delecluse; George Miller
Journal:  Virology       Date:  2009-02-15       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.